Oral Antibiotics in Germany and the Netherlands in Primary Care from 2012

Oral Antibiotics in Germany and the Netherlands in Primary Care from 2012 – 2016: A Comparison

Gradl G Teichert M Kieble M Werning J Schulz M

Poster 46th ESCP Symposium on Clinical Pharmacy (Best Poster Award).
Heidelberg, 09.-11.10.2017. Programme and Abstract Book PE007, p. 166
Int. J. Clin. Pharm. 40, 1 (2018) 295.

ESCP-2017_Poster_PE007_Oral_antibiotics

Conflicts of interests: none declared

Zielpreise für Leitsubstanzen: Verantwortungsteilung zwischen Arzt und Apotheker

Marktanteilsanalyse zum TK-Rabattvertrag

Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: A cohort study.

Switching the pharmaceutical dosage form of extended-release valproate is associated with therapeutic modification of antiepileptic therapy

Effect of switching branded risedronate to branded or generic alendronate on medication compliance with weekly bisphosphonates: a cohort study utilizing the dapi prescription claims database

Medication persistence with ginkgo biloba drugs of different dosage strengths - Persistenz bei Ginkgo biloba-Arzneimitteln unterschiedlicher Wirkstärke.

Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany